Clinical Trial for the Evaluation of Melatonin in the Treatment of Pressure Ulcers

Launched by FUNDACION RIOJA SALUD · May 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a cream containing melatonin on pressure ulcers, which are painful sores that can develop when someone is in one position for a long time. The researchers believe that melatonin can help reduce the size of these ulcers better than standard treatments because it helps protect cells from damage and promotes healing. The trial is looking for participants who are adults over 18 years old and have at least one serious pressure ulcer that fits certain criteria.

To be eligible for the trial, participants must have a specific type of pressure ulcer that is classified as category II, III, or IV and must have a wound size between 1 and 100 square centimeters. People who are currently receiving chemotherapy or have a life expectancy of less than six months are not eligible to participate. If you decide to join this study, you can expect to apply the melatonin cream as instructed and attend follow-up appointments to monitor your healing process. This trial is not yet recruiting participants, but it aims to explore a new way to improve care for those suffering from pressure ulcers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Present at least one category II, III or IV pressure ulcer according to National Group for the Study and Assessment of Pressure Ulcers (GNEAUPP) classification.
• • Ulcer area between 1 and 100 cm2.
• • People over 18 years of age who have freely given their informed consent in writing of their own volition or it has been given on their behalf by a legal guardian
• Exclusion Criteria:
• • Ulcer of category I, non-classifiable or affecting internal tissues, but with no break in the skin
• • People currently undergoing chemotherapy treatment or who have done so in the previous 6 months
• • People with a presumed life expectancy of less than 6 months or in palliative care.